Earlier this month the FDA approved Rexulti (Brexpiprazole) for the treatment of agitation in patients with dementia due to Alzheimer’s. Originally approved as an atypical antipsychotic used for schizophrenia, or an adjunct therapy for major depressive disorder,...
On May 13, 2022, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM). Pathophysiology of Type 2 Diabetes Mellitus Incretins are the...
Chlorthalidone and hydrochlorothiazide (podcast) are both thiazide diuretics. They are primarily used in the management of hypertension and occasionally for the management of edema. Hypokalemia, frequent urination, and risk for dehydration are all common adverse...
FDA-approved biosimilars have been compared to a biologic and shown to be highly similar in structure and function. They are determined to have no clinically meaningful differences in safety, purity, or potency. At the time this article was written, there are...
With insulin products continually coming to market, it can be challenging to stay current with the new information. Here is a brief overview of newly approved insulin products in the last few years, some highlights that might make them unique, and how to switch...
There may be a new option on the horizon for current insulin users! Insulin icodec is a new insulin option currently undergoing clinical trials. The most recent trial released for insulin icodec came out in November of 2020. The trial looked at the new insulin icodec,...
